New Delhi: After Pfizer-BioNTech, the US Food and Drug Administration (US FDA) has approved Moderna’s coronavirus vaccine for emergency use, potentially adding the second vaccine into America’s mass vaccination effort against a raging pandemic.
Food and Drug Administration (FDA) chief Stephen Hahn said, “With the availability of two vaccines now for the prevention of Covid-19, the FDA has taken another crucial step in the fight against this global pandemic.”
The development comes a day after advisors to the FDA voted in favour to recommend that the agency must give Emergency Use Authorisation (EUA) to Moderna’s COVID-19 vaccine. The Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted 20-0 with one abstention to recommend EUA for the Moderna vaccine .
Earlier this month, the FDA had approved the emergency use authorisation of a Covid-19 vaccine developed by Pfizer and BioNTech.
Moderna’s vaccine is based on the same technology as Pfizer’s – mRNA. The actual virus is not embedded inside these vaccines and people who get the shots can’t catch the virus from it. Instead, the vaccine contains a piece of genetic code that trains the body’s immune system to recognize the spike protein on the surface of the Covid-19 virus and helps mount an organic defence when the attack comes.